5 Accused of Stealing Drug Secrets From GlaxoSmithKline
From “5 Accused of Stealing Drug Secrets From GlaxoSmithKline”
New York Times (01/21/16) Thomas, Katie
Five people, including two research scientists, were indicted by federal prosecutors in Philadelphia on charges of stealing trade secrets about drugs to treat cancer and other diseases from British drug giant GlaxoSmithKline. According to prosecutors, GlaxoSmithKline scientist Yu Xue emailed and downloaded confidential information about company products to associates who planned to sell and market the trade secrets through a company they set up in China, called Renopharma. Former company scientist Lucy Xi is also believed to have emailed confidential information. Some of the documents involved a monoclonal antibody, a type of cancer treatment, that the company was developing. The indictment, unsealed on Wednesday, describes Ms. Xue, 45, as the co-leader of the company’s project to develop the drug. Federal prosecutors with the Eastern District of Pennsylvania said that to hide their crime, Ms. Xue and two other associates, Tao Li and Yan Mei, agreed to put the proceeds in the name of Ms. Xue’s twin sister, Tian Xue, who was also charged. Prosecutors noted that Ms. Xi worked with Ms. Xue at Glaxo and was married to Mr. Mei. Glaxo said in a statement that it had been cooperating with federal authorities and “we do not believe the breach has had any material impact” on the company’s business or research and development activity.